Pro-inflammatory diets associated with worse outcomes for stage III colon cancer

Share :
Published: 1 Jun 2025
Views: 147
Rating:
Save
Dr Sara K Char - Dana-Farber Cancer Institute, Boston, USA

Dr Schar talks to ecancer at ASCO 2025 about results from a large, prospective cohort study showing that eating a less inflammatory diet may reduce the risk of death for patients with stage III colon cancer. 

To assess the effects of diet on the risk of colon cancer recurrence, the diet habits of a subset of patients enrolled in the phase 3 CALGB/SWOG 80702 clinical trial were analysed in a prospective cohort study.

The CALGB/SWOG 80702 clinical trial tested 3 months vs. 6 months of adjuvant chemotherapy, with or without celecoxib, an anti-inflammatory medication.